PERSON
Pfizer CEO Albert Bourla to Engage with Activist Investor Starboard Value on Strategic Overhaul
Pfizer, Albert Bourla, Starboard Value, activist investor, pharmaceutical industry, strategic overhaul, post-COVID challenges
Pfizer Terminates Development of Oral RSV Medication Sisunatovir Due to Ongoing Challenges
Pfizer, ReViral, RSV, Sisunatovir, Acquisition, Clinical Development, Termination
2024 Nobel Prize in Chemistry Awarded to Trio for Groundbreaking Protein Research
Nobel Prize in Chemistry 2024, Protein Structure Prediction, Computational Protein Design, David Baker, Demis Hassabis, John Jumper
Novo Nordisk and Viatris Settle Patent Dispute Over Ozempic and Wegovy, Keeping Generic Entry Date Undisclosed
Novo Nordisk, Viatris, Mylan Pharmaceuticals, Ozempic, Wegovy, Patent Dispute, Generic Entry Date, Settlement Agreement
Pfizer’s Former Executives Back Activist Investor Starboard’s Revamp Plan
Pfizer, Starboard Value, activist investor, Ian Read, Frank D’Amelio, Albert Bourla, pharmaceutical industry, corporate governance
Judo Bio Launches with $100M to Pioneer Kidney-Targeted siRNA Therapies
Judo Bio, siRNA therapies, kidney diseases, oligonucleotide medicines, STRIKE platform, megalin-STRIKERS, renal diseases, genetic medicines.
Judo Bio Launches with $100 Million to Revolutionize Kidney Drug Delivery
Judo Bio, Kidney drug delivery, Biotech startup, Pharmaceutical innovation, $100 million funding
Lilly’s Obesity Drug Shortage Resolved, Novo’s Continues Amid Industry Efforts to Boost Manufacturing
Eli Lilly, obesity drug shortage, Mounjaro, Zepbound, Novo Nordisk, Wegovy, GLP-1 drugs, pharmaceutical manufacturing, weight loss drugs.
Gene Therapy Pioneer Jim Wilson Launches Franklin Biolabs, Expanding Genetic Medicine Services
Jim Wilson, Franklin Biolabs, Gene Therapy, Genetic Medicine Services, Rare Diseases, Adeno-Associated Viruses (AAVs)
Mendaera Secures $73M Series B Funding to Revolutionize Mainstream Medical Procedures with Robotics and AI
Mendaera, Series B funding, robotics, AI, medical procedures, healthcare technology, Threshold Ventures